Brokerages Set Bicara Therapeutics Inc. (NASDAQ:BCAX) PT at $36.67
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month […]
